Akeso (HKSE:09926) FCF Margin % : -106.39% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Akeso FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Akeso's Free Cash Flow for the six months ended in Dec. 2023 was HK$-988 Mil. Akeso's Revenue for the six months ended in Dec. 2023 was HK$929 Mil. Therefore, Akeso's FCF Margin % for the quarter that ended in Dec. 2023 was -106.39%.

As of today, Akeso's current FCF Yield % is 4.05%.

The historical rank and industry rank for Akeso's FCF Margin % or its related term are showing as below:

HKSE:09926' s FCF Margin % Range Over the Past 10 Years
Min: -6991.5 Med: -642.7 Max: 35.09
Current: 35.09

During the past 6 years, the highest FCF Margin % of Akeso was 35.09%. The lowest was -6991.50%. And the median was -642.70%.

HKSE:09926's FCF Margin % is ranked better than
96.07% of 1044 companies
in the Biotechnology industry
Industry Median: -146.375 vs HKSE:09926: 35.09

Akeso FCF Margin % Historical Data

The historical data trend for Akeso's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akeso FCF Margin % Chart

Akeso Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-642.70

-761.15

-243.88

35.09

Akeso Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial						-1,103.16	-540.23	-172.21	67.77	-106.39

Competitive Comparison of Akeso's FCF Margin %

For the Biotechnology subindustry, Akeso's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Akeso's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Akeso's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Akeso's FCF Margin % falls into.

Akeso FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Akeso's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	1737.23	/	4950.72
	=	35.09 %

Akeso's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-988.425	/	929.049
	=	-106.39 %

Akeso FCF Margin % Related Terms

Thank you for viewing the detailed overview of Akeso's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Akeso (HKSE:09926) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Akeso Inc (HKSE:09926) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

AKESF:USA 4RY:Germany

Address

6 Shennong Road, Torch Development Zone, Guangdong Province, Zhongshan, CHN, 528437

Website

https://www.akesobio.com

Akeso Inc is an investment holding company. The Company's subsidiaries were involved in research and development, production and commercialization of biopharmaceutical products. The company currently has a pipeline of over 30 drugs for the treatment of diseases like cancers, autoimmune diseases, inflammation and metabolic diseases, 17 of which have entered the clinical stage, including two first-in-class bi-specific antibody drugs (PD-1/CTLA-4 and PD-1/VEGF). The majority of the company's revenue is earned in Mainland China.

Akeso (HKSE:09926) Headlines

No Headlines